| Patient | Elizabeth Barrett Browning |
|---|---|
| Date of birth | 1806-03-06 |
| Identifiers | MRN HR-NI026-SYN-TD; SSN (made up) 000-26-4157 |
| Document date | 1845-07-13 |
| Author | Clementine Haverford-Asante, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Barrett Browning is a 39-year-old poet with bronchiectasis diagnosed four months ago, long-term morphine therapy that she is slowly reducing by her own choice, and prolonged grief disorder in weekly grief therapy, who comes for her yearly preventive visit. She does airway clearance twice a day, and her sputum is down to about a tablespoon a day without blood. She takes morphine solution 4 mL (8 mg) twice daily, reduced in two steps from 5 mL since April. She has been out by car twice this summer and walked in the garden. She is writing well and has finished a set of poems she began in the spring. Her periods are regular. She has no new concerns. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 39 |
| Lungs | Stable on airway clearance; no exacerbation since diagnosis |
| Medicines | Morphine solution 8 mg twice daily; naloxone at home; vitamin D3 1819 units daily |
| Mood | PHQ-2 1; finishing the sixteenth grief therapy session this week |
Health risk assessment. Completed by the patient on paper at home and reviewed with her by Dr. Haverford-Asante. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair, and better than in the spring |
| Psychosocial | Absorbing work and many correspondents; grief easing; financially secure |
| Substance use | AUDIT-C 0; prescribed morphine taken as directed; no other drugs |
| Tobacco | Never uses tobacco; no smokers in her room |
| Physical activity | Home exercise program three days a week; walks in the garden in fine weather |
| Nutrition | Small frequent meals and one supplement drink a day; dairy daily |
| Sleep | About six hours, better than in the spring |
| Safety | No falls; morphine kept locked; naloxone at home; no firearm at home; feels safe at home (intimate partner violence screen negative) |
| Sexual and reproductive health | Not sexually active; not planning pregnancy; periods regular |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss; weight rising |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No sinus pain or discharge |
| Cardiovascular | Negative | Occasional palpitations, less often than in the spring; no chest pain or ankle swelling |
| Respiratory | Positive | Morning cough with about a tablespoon of sputum; no blood since the first month; breathless on the second flight of stairs |
| Gastrointestinal | Positive | Stools firm every two days on morphine; no abdominal pain |
| Genitourinary | Negative | Regular periods; no urinary symptoms |
| Musculoskeletal | Positive | Mild upper back ache at the end of a long day of writing, as for many years; no new pain |
| Integumentary | Negative | No rashes or changing moles |
| Breast | Negative | No lump, pain or nipple discharge |
| Neurological | Negative | No drowsiness, headaches or weakness |
| Psychiatric | Negative | Mood better; no thoughts of self-harm; PHQ-2 1 |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Morphine sulfate 2 mg/mL oral solution, 5 mL (10 mg) by mouth twice daily, morning and bedtime (20 mg a day; long-standing prescription, continued) | 5 mL (10 mg) twice daily, morning and bedtime | Oral route | 1838-03-01 to 1845-04-19 | completed | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911 | As needed for suspected overdose; keep two devices at home | Nasal route | 1845-03-16 | active | S |
| Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (1819 units) by mouth daily | Two tablets daily | Oral route | 1845-03-16 | active | S |
| Morphine sulfate 2 mg/mL oral solution, 4.5 mL (9 mg) by mouth twice daily, morning and bedtime (18 mg a day) | 4.5 mL (9 mg) twice daily, morning and bedtime | Oral route | 1845-04-20 to 1845-06-14 | completed | S |
| Morphine sulfate 2 mg/mL oral solution, 4 mL (8 mg) by mouth twice daily, morning and bedtime (16 mg a day) | 4 mL (8 mg) twice daily, morning and bedtime | Oral route | 1845-06-15 to 1845-10-18 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1845-07-13 | Body height | 157 | cm | S |
| 1845-07-13 | Body weight | 43.8 | kg | S |
| 1845-07-13 | Body mass index (BMI) [Ratio] | 17.8 | kg/m2 | S |
| 1845-07-13 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1845-07-13 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1845-07-13 | Heart rate | 82 | /min | S |
| 1845-07-13 | Respiratory rate | 16 | /min | S |
| 1845-07-13 | Body temperature | 36.7 | Cel | S |
| 1845-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1845-07-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1845-07-13 | Total score [AUDIT-C] | 0 | {score} | S |
Vital signs recorded on 1845-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Thin but well; weight 43.8 kg, BMI 17.8; blood pressure 106/66 |
| Skin | No suspicious moles |
| Neck | Thyroid normal; no nodes |
| Breasts | Clinical breast examination declined; no concerns raised |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Respiratory | A few coarse crackles at the left base that clear partly with coughing; no wheeze |
| Abdomen | Soft and non-tender |
| Musculoskeletal | Mild thoracic kyphosis; no spinal tenderness |
| Pelvic | Speculum examination with a chaperone present; cervix normal; sample taken for HPV testing |
| Psychiatric | Bright, engaged, and able to speak of her brother briefly without distress overwhelming her |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic cough with daily yellow sputum, occasional streaks of blood, and breathlessness on stairs, worse in winter, for several years after an illness with blood in the sputum about eight years ago; tuberculosis, nontuberculous mycobacteria and bronchiectasis to be distinguished | resolved | confirmed | R05.3 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; it echoes her documented chest illness (D). |
| Non-cystic fibrosis bronchiectasis of the left lower lobe and lingula with chronic Haemophilus influenzae infection and mild airflow obstruction (Bronchiectasis Severity Index 3, mild); tuberculosis and nontuberculous mycobacterial disease excluded; synthetic modern diagnosis chosen for a historical chest illness whose cause is disputed | active | confirmed | J47.9 | S — Synthetic modern diagnosis; the nature of her historical chest illness remains undetermined (R, disputed). |
| Long-term prescribed opioid therapy (oral morphine 20 mg a day for many years, for cough, sleeplessness and palpitations), with expected physiological dependence; no opioid use disorder on DSM-5-TR assessment | active | confirmed | Z79.891 | S — Synthetic modern problem anchored to her documented prescribed opium (D); tolerance and withdrawal on prescribed opioids do not count toward opioid use disorder. |
| Prolonged grief disorder after the drowning of her closest brother five years ago, with yearning, self-blame, avoidance of reminders of the sea, and depressive symptoms (PHQ-9 12); no suicidal ideation | active | confirmed | F43.81 | S — Synthetic modern diagnosis anchored to her documented bereavement (D); not a claim about her real mental health. |
| Vitamin D deficiency (25-hydroxyvitamin D 15 ng/mL) in a woman who rarely goes outdoors | resolved | confirmed | E55.9 | S — Synthetic finding at intake; repleted by twelve weeks. |
| Underweight (BMI 16.8) with a small appetite | active | confirmed | R63.6 | S — Synthetic finding at intake. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 106/66 mmHg |
| Depression screening | Completed today | PHQ-2 score 1; already in treatment for grief with PHQ-9 at each chronic-care visit |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Tobacco use | Completed today | Never uses tobacco |
| Intimate partner violence screening | Completed today | Negative; feels safe at home |
| Lipid screening and statin assessment | Not indicated | Statin assessment begins at 40; no risk factors |
| Diabetes screening | Not indicated | Underweight, with a normal glucose at her first visit |
| Breast cancer screening | Due | Biennial mammography from 40, next year |
| Cervical cancer screening | Completed today | No record of earlier screening; high-risk HPV test collected today; repeat every five years if negative |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| HIV screening | Up to date | Negative at her first visit, as part of the tuberculosis work-up |
| Hepatitis C screening | Completed today | Once for adults 18 to 79; sent today |
| Hepatitis B screening | Completed today | Once for all adults (surface antigen, surface antibody and core antibody); sent today before the first vaccine dose |
| Osteoporosis screening | Up to date | DXA three months ago: Z-scores within the expected range; vitamin D repleted |
| Folic acid | Not indicated | Not sexually active and not planning pregnancy; she will start folic acid and review her medicines before any pregnancy |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap; no record of a booster within ten years |
| Pneumococcal vaccine | Completed today | PCV20 for chronic lung disease; series complete |
| Hepatitis B vaccine | Completed today | No record of vaccination; dose 1 of 2 today, dose 2 at the autumn review |
| Influenza vaccine | Due | At the autumn review; yearly for her lung disease |
| COVID-19 vaccine | Due | Discuss in the autumn with the influenza vaccine |
| Human papillomavirus vaccine | Not indicated | Routine vaccination ends at 26; shared decision-making to 45: not sexually active, and she chose not to have it |
| Naloxone and opioid safety | Up to date | Two naloxone devices at home and in date; morphine in a locked box |
Immunizations given today: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Pneumococcal conjugate vaccine, 20-valent (PCV20); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Seven-month review in the autumn with the PHQ-9, sputum culture, the second hepatitis B dose and the influenza vaccine. Hepatitis B, hepatitis C and HPV results by phone. Next preventive visit in one year. Next scheduled visit 1845-10-19: seven-month review after an exacerbation: lungs, opioid therapy, mood, safety, weight, and vaccines. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any chest infection or bleeding, including hospital care, and would want her poems and papers kept safe if she were ever too ill to manage them. She named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly. [S]